Optimind Pharma Stock Price

CNSX:OMNDCA$1.0mHealthcare

OMND Share Price Performance

OMND Community Fair Values

View all narratives

Recent OMND News & Updates

No updates

Optimind Pharma Corp. Key Details

Last Reported Earnings

Feb 28, 2025

Next Reporting Earnings

n/a

Earnings per share (EPS): -0.0021
Gross Margin: 58.27%
Net Profit Margin: -182.32%
Debt/Equity Ratio: -167.9%

View full report ›

Optimind Pharma Corp. Competitors

About OMND

Founded: n/a
Employees: n/a
CEO: David Goodman
WebsiteView website: optimindpharma.com

Optimind Pharma Corp. provides psychedelic therapies in Canada. The company offers psychedelic-like therapies for the treatment of post-traumatic stress syndrome, anxiety, depression, and other mental illnesses and disabilities through ketamine-assisted treatment and other psychedelic enhanced psychotherapy modalities. It also prescribes medical cannabis and other alternative treatments for various medical ailments through its clinics. Optimind Pharma Corp. is headquartered in Toronto, Canada.

Canadian Market Performance

7 Days: 0.6%
3 Months: 12.0%
1 Year: 16.4%
Year to Date: 9.4%

The market has been flat over the last week. More promisingly, the market is up 16% over the past year. Looking forward, earnings are forecast to grow by 12% annually. Market details ›

The Big Beautiful Deficit

Richard Bowman

July 2025

Donald Trump's "One Big Beautiful Bill" has been signed into law. It provides stimulus via increased spending, tax cuts and tax incentives that support Trump’s agenda...

Last Week

OMND Share Price Performance

OMND Community Fair Values

Recent OMND News & Updates

Optimind Pharma Corp. Key Details

Optimind Pharma Corp. Competitors

Vibe Growth

Enlighta

Revitalist Lifestyle and Wellness

Imagin Medical

Frequency Exchange

Aurora Spine

MyndTec

TripSitter Clinic

The Big Beautiful Deficit

🎢 From Panic to Peak: Q2’s Wild Ride and What’s Next